In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
ImmunoVaccine Technologies to Develop Pseudomonas Vaccine from Yokohama City University
Bioject and ImmunoVaccine Technologies Announce Research Collaboration
ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
Nabi receives patents on Staphylococcus Epidermidis vaccine and immune globulin
CEL-SCI issued vaccine patents
Crucell and NIH to develop Ebola vaccine